Literature DB >> 22398072

Is patient reported outcome (PRO) affected by different follow-up regimens in inflammatory bowel disease (IBD)? A one year prospective, longitudinal comparison of nurse-led versus conventional follow-up.

Lars-Petter Jelsness-Jørgensen1, Tomm Bernklev, Magne Henriksen, Roald Torp, Bjørn Moum.   

Abstract

OBJECTIVE: Specialist nurses have become increasingly involved in the management of Inflammatory Bowel Disease (IBD). The objectives of this study were to investigate the impact of nurse-led versus conventional follow-up on patient outcomes, such as quality of life, worries and time from relapse to start of treatment.
METHODS: Patients completed the Short Form 36 (SF-36), Inflammatory Bowel Disease Questionnaire (N-IBDQ) and the Rating Form of IBD Patient Concerns (RFIPC) at baseline and after 1 year. Socio-demographic and clinical variables were obtained at V1 and V2. In addition the amount of e.g., relapses, hospitalisations, time from relapse to start of treatment, sick-leave, unscheduled visits or telephone calls was recorded during the follow-up period.
RESULTS: A total of 140 patients were included; ulcerative colitis (UC) n=92, Crohn's disease (CD) n=48, mean age 46.9 and 40.0 years old, respectively. One hundred and thirty three patients attended the follow-up after 1 year. After 1 year there were no differences between the groups in relation to quality of life, worries, amount of relapse, sick-leave, hospitalisations or surgery. Participants in nurse-led follow-up had a significantly (p<0.05) shorter interval from the start of a relapse to the start of treatment.
CONCLUSIONS: Nurse-led follow-up of IBD patients produces PRO results comparable to that of gastroenterologists and may shorten the interval from the beginning of a relapse to the start of treatment.
Copyright © 2012 European Crohn's and Colitis Organisation. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22398072     DOI: 10.1016/j.crohns.2012.01.021

Source DB:  PubMed          Journal:  J Crohns Colitis        ISSN: 1873-9946            Impact factor:   9.071


  8 in total

Review 1.  Patient-reported outcome measures in inflammatory bowel disease.

Authors:  Wael El-Matary
Journal:  Can J Gastroenterol Hepatol       Date:  2014-11

Review 2.  British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults.

Authors:  Christopher Andrew Lamb; Nicholas A Kennedy; Tim Raine; Philip Anthony Hendy; Philip J Smith; Jimmy K Limdi; Bu'Hussain Hayee; Miranda C E Lomer; Gareth C Parkes; Christian Selinger; Kevin J Barrett; R Justin Davies; Cathy Bennett; Stuart Gittens; Malcolm G Dunlop; Omar Faiz; Aileen Fraser; Vikki Garrick; Paul D Johnston; Miles Parkes; Jeremy Sanderson; Helen Terry; Daniel R Gaya; Tariq H Iqbal; Stuart A Taylor; Melissa Smith; Matthew Brookes; Richard Hansen; A Barney Hawthorne
Journal:  Gut       Date:  2019-09-27       Impact factor: 23.059

Review 3.  Psychometric validation of the SF-36® Health Survey in ulcerative colitis: results from a systematic literature review.

Authors:  Aaron Yarlas; Martha Bayliss; Joseph C Cappelleri; Stephen Maher; Andrew G Bushmakin; Lea Ann Chen; Alireza Manuchehri; Paul Healey
Journal:  Qual Life Res       Date:  2017-08-28       Impact factor: 4.147

4.  Perspectives and attitudes of young patients with inflammatory bowel disease: symptoms, burden of disease and communication with their healthcare professionals.

Authors:  C Alexakis; G Davies; J Stephens; S Clark; S Rogers; A Poullis
Journal:  Frontline Gastroenterol       Date:  2013-12-13

5.  Nirvana: A Qualitative Study of Posttraumatic Growth in Adolescents and Young Adults with Inflammatory Bowel Disease.

Authors:  Qiwei Wu; Pingting Zhu; Xinyi Liu; Qiaoying Ji; Meiyan Qian
Journal:  Children (Basel)       Date:  2022-06-13

6.  Multidisciplinary Management of Spondyloarthritis-Related Immune-Mediated Inflammatory Disease.

Authors:  Fernando Rizzello; Ignazio Olivieri; Alessandro Armuzzi; Fabio Ayala; Vincenzo Bettoli; Luca Bianchi; Luca Cimino; Antonio Costanzo; Antonio Cristaudo; Salvatore D'Angelo; Marco Daperno; Anna Chiara Fostini; Mauro Galeazzi; Michele Gilio; Paolo Gionchetti; Paolo Gisondi; Ennio Lubrano; Antonio Marchesoni; Annamaria Offidani; Ambrogio Orlando; Daniela Pugliese; Carlo Salvarani; Raffaele Scarpa; Maurizio Vecchi; Giampiero Girolomoni
Journal:  Adv Ther       Date:  2018-03-07       Impact factor: 3.845

7.  The impact of nurse-led annual telephone follow-up of patients with inflammatory bowel disease.

Authors:  Palle Bager
Journal:  BMJ Qual Improv Rep       Date:  2014-11-07

8.  Effects of introduction of an inflammatory bowel disease nurse position on healthcare use.

Authors:  Christine Martinez-Vinson; Sebastien Le; Audrey Blachier; Maud Lipari; Jean-Pierre Hugot; Jerome Viala
Journal:  BMJ Open       Date:  2020-05-11       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.